With 44,000 new diagnoses each year, non-small cell lung cancer is the second most frequent neoplasm in Italy after breast ...

Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy have developed ...

Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted ...

Kolkata: Cancer care is set to take a leap forward across multiple city hospitals that are enhancing oncology units even as ...

A team led by the Institute for Bioengineering of Catalonia (IBEC) and the Hospital del Mar Research Institute has developed ...

12, 2024 — Researchers examined the impact of obesity in relation to treatment and mortality from data on over 500,000 lung cancer patients. This study suggests that immunotherapy may not be the ...

“This data supports our hypothesis of personalized immunotherapy with Bria-OTS™, potentially leading to new and effective ...

Heather Wakelee, MD, Stanford University, discusses the pros and cons of different durations of immunotherapy in non-small cell lung cancer (NSCLC) and the future outlook for patient-specific care.

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

BriaCell Therapeutics (TSX:BCT) is reporting that the first metastatic breast cancer patient treated with its Bria-OTS ...

本文仅供中国大陆地区执业的医学药学专业人士参考，如您非前述专业人士，请离开本页面 本文仅供医疗卫生等专业人士参考审批码：TML0038594，有效期为 2025-01-21 至 2026-01-20，资料过期，视同作废内容策划：方程项目审核：于轩题图来源：图虫创意参考文献：[1]Fan Y, Zhou JY, Zhao Y, et al. Efficacy, safety, and ...